Ocrelizumab modifies circulating immune asset in relapsing-remitting multiple sclerosis subjects

被引：0
|
作者：
Abbadessa, Gianmarco [1 ]
Bruzzaniti, Sara [2 ]
Miele, Giuseppina [1 ]
Piemonte, Erica [3 ]
Signoriello, Elisabetta [1 ]
Lus, Giacomo [1 ]
Matarese, Giuseppe [3 ]
Galgani, Mario [3 ]
Bonavita, Simona [1 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Clin Neurol 2, Naples, Italy
[2] Univ Naples Federico II, Dipartimento Biol, Naples, Italy
[3] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 429卷
关键词：
D O I：
10.1016/j.jns.2021.118820
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
118820
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [21] Depression in relapsing-remitting multiple sclerosis
    Mendes, MF
    Tilbery, CP
    Balsimelli, S
    Moreira, MA
    Barao-Cruz, AM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (3A) : 591 - 595
  • [22] Relapsing-remitting tumefactive multiple sclerosis
    Selkirk, SM
    Shi, J
    MULTIPLE SCLEROSIS, 2005, 11 (06): : 731 - 734
  • [23] Autohemotherapy for relapsing-remitting multiple sclerosis
    Mubaidin, AF
    Horani, KA
    Dehayyat, MA
    Shehab, M
    Abu-Ruman, IA
    Shurbaji, AA
    Kurdi, A
    Hiari, M
    Khakish, M
    Harahsheh, O
    Dabbas, M
    NEUROLOGY, 2001, 56 (08) : A75 - A75
  • [24] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Guo, Rui
    Zhang, Fubo
    Zhang, Chao
    Dong, Shuai
    Zhou, Hongyu
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [25] A non-inferiority study of rituximab versus ocrelizumab in relapsing-remitting multiple sclerosis
    Roos, I.
    Hughes, S.
    MacDonnell, G.
    Boz, C.
    Alroughani, R.
    Ozakbas, S.
    Buzzard, K.
    Skibina, O.
    Van der Walt, A.
    Butzkueven, H.
    Lechner-Scott, J.
    Kuhle, J.
    Terzi, M.
    Laureys, G.
    Van Hijfte, L.
    John, N.
    Grammond, P.
    Grand'Maison, F.
    Soysal, A.
    Sellebjerg, F.
    Gray, O.
    Magyari, M.
    Kalincik, T.
    Msbase and Danish Sclerosis Registry Study Grp
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 951 - 953
  • [26] Progressive multifocal encephalopathy in the first patient with relapsing-remitting multiple sclerosis treated with ocrelizumab
    Puig Casadevall, M.
    Alvarez Bravo, G.
    Coll-Martinez, C.
    Quiroga-Varela, A.
    Robles-Cedeno, R.
    Gonzalez del Rio, M.
    Salavedra-Pont, J.
    Miguela, A.
    Gich, J.
    Ramio-Torrenta, L.
    Boix-Lago, A.
    Laguillo-Sala, G.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 679 - 680
  • [27] Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis
    Escribano, Begona M.
    Aguilar-Luque, Macarena
    Bahamonde, Carmen
    Conde, Cristina
    Lillo, Rafael
    Sanchez-Lopez, Fernando
    Giraldo, Ana I.
    Cruz, Antonio H.
    Luque, Evelio
    Gascon, Felix
    Aguera, Eduardo
    Tunez, Isaac
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (31) : 4876 - 4880
  • [28] Rituximab in relapsing-remitting multiple sclerosis
    Schrijver, Hans M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24): : 2645 - 2645
  • [29] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [30] Fingolimod for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Tramacere, Irene
    Firwana, Belal
    Pacchetti, Ilaria
    Palumbo, Roberto
    Filippini, Graziella
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
12345